Dr. Andrea Shimada – Clinical Oncologist in São Paulo, Brazil

Dr. Andrea Shimada is a clinical oncologist associated with Hospital Sírio-Libanês in São Paulo, Brazil, where she is part of the hospital's specialized Oncology Center. The hospital's current oncology team identifies her principal areas of specialization as breast cancer and lung cancer.

Her professional activities are focused on clinical oncology and the medical management of cancer. She has also been involved in scientific research and medical education, with publicly available academic records showing substantial research activity in cancer biology, molecular oncology, tumor markers, and clinical oncology.

Specialization in Clinical Oncology

Clinical oncology is a medical specialty focused on the diagnosis, treatment, and long-term management of cancer. Clinical oncologists may use systemic therapies such as chemotherapy, hormonal therapy, targeted therapies, immunotherapy, and other treatments according to the patient's disease characteristics.

Treatment planning is individualized. Factors such as cancer type, stage, pathology, molecular profile, previous treatment, age, general health, and patient preferences can all influence the recommended treatment strategy.

Dr. Andrea Shimada's official listing within the Sírio-Libanês Oncology Center identifies breast and lung cancer as her areas of specialization.

Breast Cancer Expertise

Breast cancer is a major area of modern oncology and can include multiple biological subtypes requiring different treatment approaches. Diagnosis and treatment may involve breast imaging, biopsy, pathology, surgery, radiation oncology, clinical oncology, genetics, and supportive care.

Systemic treatment may include endocrine therapy, chemotherapy, targeted therapy, immunotherapy, or combinations depending on tumor biology and stage.

Dr. Shimada works within the multidisciplinary environment of the Hospital Sírio-Libanês Oncology Center, where cancer specialists are organized according to areas of expertise.

Lung Cancer Expertise

Dr. Shimada also specializes in lung cancer. Contemporary lung cancer management increasingly incorporates molecular testing and biomarkers, which may help physicians identify appropriate targeted or immune-based treatment options for selected patients.

Depending on the patient's diagnosis and stage, care may involve pulmonology, thoracic surgery, pathology, radiology, radiation oncology, and clinical oncology. The multidisciplinary approach is particularly important for complex lung cancer cases.

Research and Academic Interests

Dr. Andrea Shimada has an academic profile involving research in cancer biology, tumor markers, molecular oncology, and clinical oncology. Publicly available research records list dozens of publications associated with her work at Hospital Sírio-Libanês.

Her research activity includes work concerning breast cancer and molecular or clinical factors that can influence cancer treatment. A 2026 publication involving her examined the clinical impact and clinicopathological correlations of Oncotype DX in hormone-receptor-positive/HER2-negative early breast cancer in a large Brazilian cohort.

Research of this type reflects the growing importance of biomarkers and molecular information in individualized cancer care.

Precision Medicine in Oncology

Modern cancer treatment increasingly seeks to match therapy to the characteristics of an individual tumor. Molecular testing, genomic information, receptor status, and other biomarkers may contribute to treatment selection for appropriate patients.

For breast cancer, for example, information about hormone receptors and HER2 can influence treatment planning. For lung cancer, molecular alterations can also help determine whether targeted therapies may be appropriate.

The role of the clinical oncologist is to interpret these findings together with the patient's clinical history and other diagnostic information.

Medical Education and Continuing Oncology Development

Cancer medicine changes rapidly as new therapies and diagnostic technologies become available. Medical professionals therefore require continuing education and engagement with scientific research.

Hospital Sírio-Libanês maintains a major teaching and research structure and regularly participates in scientific conferences and oncology education. The hospital's oncology content also features Dr. Shimada in educational discussions, including a Sírio-Libanês oncology program focused on oncogeriatrics and cancer care for older adults.

This reflects the broader importance of individualized oncology care, particularly when treatment decisions must account for age, functional status, comorbidities, and patient goals.

Multidisciplinary Cancer Treatment

Breast and lung cancers frequently require cooperation among several medical disciplines. Depending on the case, treatment teams may include clinical oncologists, surgeons, radiation oncologists, radiologists, pathologists, genetic specialists, nurses, nutrition professionals, psychologists, and rehabilitation specialists.

Multidisciplinary assessment can help integrate diagnostic information and develop a coordinated treatment strategy.

Hospital Sírio-Libanês in São Paulo

Dr. Andrea Shimada practices as part of the Hospital Sírio-Libanês Oncology Center in São Paulo. The hospital's official oncology team lists her alongside specialists dedicated to different tumor types and cancer subspecialties.

Hospital Sírio-Libanês also provides an International Patient Center for people seeking healthcare in Brazil and emphasizes technology, innovation, multidisciplinary care, education, and research.

International Patients Seeking Cancer Treatment

For international patients researching breast cancer or lung cancer treatment in Brazil, Dr. Andrea Shimada's specialist profile may be relevant when considering oncology consultation in São Paulo.

Before international treatment, patients should ideally provide pathology reports, biopsy results, imaging, laboratory tests, previous treatment records, medication lists, and other relevant medical documentation. The treating oncology team can then determine what additional assessment is required.

Key Areas of Expertise

• Clinical Oncology

• Medical Oncology

• Breast Cancer

• Lung Cancer

• Molecular Oncology

• Cancer Biology

• Tumor Markers

• Personalized Cancer Care

• Multidisciplinary Oncology

• Oncology Research

• Evidence-Based Cancer Treatment

Dr. Andrea Shimada combines clinical oncology practice at Hospital Sírio-Libanês with scientific and educational involvement in cancer medicine. Her listed specialization in breast and lung cancer, together with research activity in molecular and clinical oncology, makes her profile relevant to patients seeking specialized cancer care in São Paulo.